CGEN Competitors & Alternatives
Compare Compugen with similar stocks in the same industry
Biotechnology
CGEN
Main Stock$2.02
-0.98%
Tradestie Score
45
Market Cap
$149.66M
P/E Ratio
5.4
Revenue Growth
102.1%
Analyst Upside
+137.6%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 4/10
Drug Discovery Biotech
Drug Design
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.80
|
$240.89M | - | 45 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$5.05
+3.27%
|
$231.77M | - | 56 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.85
-2.76%
|
$227.00M | - | 50 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$19.15
+156.36%
|
$211.22M | - | 32 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.38
-6.24%
|
$202.58M | - | 40 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$13.04
-3.41%
|
$199.71M | - | 42 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
+0.03%
|
$180.53M | - | 54 | Compare |
|
MCRB
Seres Therapeutics, Inc.
|
$1.41
|
$179.47M | - | 44 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
+0.89%
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.20
+0.47%
|
$154.27M | - | 54 | Compare |
More CGEN Analysis
Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry